Cargando…

Remnant-Like Particle Cholesterol and the Risk of Major Adverse Cardiovascular Events: A Systematic Review and Meta-Analysis

Background: The remnant-like particle cholesterol (RLP-C) has been demonstrated to be associated with residual cardiovascular risk. The meta-analysis aimed to evaluate the impact of baseline RLP-C on the incidence of major cardiovascular adverse events (MACEs) in patients with coronary artery diseas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Jie, Wang, Yuangengshuo, Xi, Ziwei, Ma, Yue, Shao, Chunli, Wang, Wenyao, Tang, Yi-Da
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9781984/ https://www.ncbi.nlm.nih.gov/pubmed/36547449 http://dx.doi.org/10.3390/jcdd9120452

Ejemplares similares

Elevated Remnant Cholesterol is Associated with Adverse Cardiovascular Outcomes in Patients with Acute Coronary Syndrome
por: Shao, QiaoYu, et al.
Publicado: (2022)

Remnant cholesterol is associated with cardiovascular mortality
por: Zhang, Kerui, et al.
Publicado: (2022)

Association between Remnant-Like Particle Cholesterol and Gamma-Glutamyltransferase in Dyslipidemic Patients
por: Kotani, Kazuhiko, et al.
Publicado: (2013)

High serum uric acid levels may increase mortality and major adverse cardiovascular events in patients with acute myocardial infarction
por: Xu, Qiyao, et al.
Publicado: (2017)

The Effects of Calculated Remnant-Like Particle Cholesterol on Incident Cardiovascular Disease: Insights from a General Chinese Population
por: Chen, Yanli, et al.
Publicado: (2021)

Reduction of Major Adverse Cardiovascular Events (MACE) after Bariatric Surgery in Patients with Obesity and Cardiovascular Diseases: A Systematic Review and Meta-Analysis
por: Sutanto, Andryanto, et al.
Publicado: (2021)

Age dependent association between remnant cholesterol and cardiovascular disease
por: Wang, Anxin, et al.
Publicado: (2021)

Long-term major adverse cardiovascular events following myocardial injury after non-cardiac surgery: meta-analysis
por: Strickland, Scarlett S, et al.
Publicado: (2023)

Cholesterol Remnants, Triglyceride-Rich Lipoproteins and Cardiovascular Risk
por: Baratta, Francesco, et al.
Publicado: (2023)

Triglyceride-Rich Lipoproteins and Remnant Cholesterol in Cardiovascular Disease
por: Heo, Ji Hye, et al.
Publicado: (2023)

Remnant Lipoprotein Cholesterol and Cardiovascular and Cerebrovascular Events in Patients with Non-Alcoholic Fatty Liver Disease
por: Pastori, Daniele, et al.
Publicado: (2018)

Remnant Cholesterol Predicts Risk of Cardiovascular Events in Patients With Myocardial Infarction With Nonobstructive Coronary Arteries
por: Gao, Side, et al.
Publicado: (2022)

Effects of risperidone and olanzapine on remnant-like lipoprotein particle cholesterol (RLP-C) in schizophrenic patients
por: Nagamine, Takahiko
Publicado: (2008)

Empagliflozin decreases remnant‐like particle cholesterol in type 2 diabetes patients with insulin resistance
por: Hattori, Sachiko
Publicado: (2017)

Remnant cholesterol and atherosclerotic cardiovascular disease: Metabolism, mechanism, evidence, and treatment
por: Wang, Kexin, et al.
Publicado: (2022)

The Association Between Remnant Cholesterol and the Estimated 10-Year Risk of a First Hard Cardiovascular Event
por: Yang, Zhen, et al.
Publicado: (2022)

Major Adverse Cardiovascular Events and Mortality Prediction by Circulating GDF-15 in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis
por: Xie, Suyi, et al.
Publicado: (2022)

High‐density lipoprotein cholesterol levels are associated with major adverse cardiovascular events in male but not female patients with hypertension
por: Wang, Xiaopu, et al.
Publicado: (2021)

Prognostic impact of estimated remnant-like particle cholesterol in patients with differing glycometabolic status: an observational cohort study from China
por: Zhao, Qi, et al.
Publicado: (2020)

Correlation between estimated plasma remnant-like particle cholesterol and vegetable fat intake in Uku town, Japan
por: Adachi, Hisashi, et al.
Publicado: (2021)

Association of remnant cholesterol and non-high density lipoprotein cholesterol with risk of cardiovascular mortality among US general population
por: Cheang, Iokfai, et al.
Publicado: (2022)

Low-density Lipoprotein Cholesterol/High-density Lipoprotein Cholesterol Ratio as Predictor of First Acute Myocardial Infarction and Major Adverse Cardiovascular Event after Intervention in Young Males
por: Li, Zhao, et al.
Publicado: (2018)

Increased estimated remnant-like particle cholesterol is associated with impaired coronary collateralization in patients with coronary chronic total occlusions
por: Gao, Ang, et al.
Publicado: (2022)

Longitudinal association of remnant cholesterol with joint arteriosclerosis and atherosclerosis progression beyond LDL cholesterol
por: Wu, Zhiyuan, et al.
Publicado: (2023)

The longitudinal association of remnant cholesterol with cardiovascular outcomes in patients with diabetes and pre-diabetes
por: Cao, Ye-Xuan, et al.
Publicado: (2020)

Contribution of Remnant Cholesterol to Coronary Atherosclerosis
por: Ohmura, Hirotoshi
Publicado: (2022)

Portal vein embolization versus dual vein embolization for management of the future liver remnant in patients undergoing major hepatectomy: meta-analysis
por: Bell, Richard J, et al.
Publicado: (2022)

Short sleep duration and the risk of nonalcoholic fatty liver disease/metabolic associated fatty liver disease: a systematic review and meta-analysis
por: Yang, Jie, et al.
Publicado: (2022)

Association of remnant cholesterol with depression among US adults
por: Wang, Yang, et al.
Publicado: (2023)

Gut Microbiota Metabolites and Risk of Major Adverse Cardiovascular Disease Events and Death: A Systematic Review and Meta‐Analysis of Prospective Studies
por: Heianza, Yoriko, et al.
Publicado: (2017)

Combined Effect of Small Dense Low-Density Lipoprotein Cholesterol (sdLDL-C) and Remnant-Like Particle Cholesterol (RLP-C) on Low-Grade Inflammation
por: Izumida, Toshihide, et al.
Publicado: (2020)

The role of remnant cholesterol beyond low-density lipoprotein cholesterol in diabetes mellitus
por: Hu, Xiangming, et al.
Publicado: (2022)

Remnant cholesterol and severity of nonalcoholic fatty liver disease
por: Huang, Hangkai, et al.
Publicado: (2023)

Efficacy and adverse events of pirfenidone in treating idiopathic pulmonary fibrosis
por: Ren, Hui, et al.
Publicado: (2017)

Placebo-Related Adverse Events in Rheumatoid Arthritis
por: Sharma, Ratna Shree, et al.
Publicado: (2022)

High Remnant Cholesterol Level Potentiates the Development of Hypertension
por: Chen, Ming-Ming, et al.
Publicado: (2022)

Risk of Major Adverse Cardiovascular Events in Patients With Rheumatoid Arthritis
por: Mal, Kheraj, et al.
Publicado: (2020)

Prediabetes as a risk factor for major adverse cardiovascular events
por: Mando, Ramy, et al.
Publicado: (2021)

Association of Prior Intracerebral Hemorrhage With Major Adverse Cardiovascular Events
por: Gaist, David, et al.
Publicado: (2022)

Comparison of HEAR and HEART Scores for Major Adverse Cardiovascular Events
por: Uyan, Umut
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_otk9nqbtmoa2iv0e9k6hmbf6b8